Appropriate management of lower respiratory tract infections in primary care

Primary Care Respiratory Journal

Volumn 13, Issue 3, 2004, Pages 159-166

  Feldman, Charles ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Acute bronchitis; COPD; Exacerbations; General practice; Lower respiratory tract infections; LRTIs; Pneumonia; Primary care

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOXYCYCLINE; KETOLIDE; MACROLIDE; METHYLXANTHINE DERIVATIVE;

ANTIBIOTIC THERAPY; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; DISEASE EXACERBATION; DRUG COST; DRUG INDICATION; FORCED EXPIRATORY VOLUME; GENERAL PRACTICE; HEALTH CARE DELIVERY; HUMAN; LOWER RESPIRATORY TRACT INFECTION; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW;

EID: 4444230754     PISSN: 14714418     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcrj.2004.02.006     Document Type: Article

References (42)

1. Macfarlane J, Holmes WF, Macfarlane R. Do hospital physicians have a role in reducing antibiotic prescribing in the community? Thorax 2000;55:153-8.
2. Macfarlane J, Holmes W, Macfarlane R, Britten N. Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. Br Med J 1997;315:1211-4.
3. Macfarlane J, Lewis SA, Macfarlane R, Holmes W. Contemporary use of antibiotics in 1089 adults presenting with acute lower respiratory tract illness in general practice in the UK: implications for developing management guidelines. Respir Med 1997;91:427-34.
4. Colgan R, Powers JH. Appropriate antimicrobial prescribing: approaches that limit antibiotic resistance. Am Fam Physician 2001;64:999-1004.
5. Ortqvist A. Treatment of community-acquired lower respiratory tract infections in adults. Eur Respir J 2002;20(Suppl 36):40s-53s.
6. Macfarlane J. Lower respiratory tract infection and pneumonia in the community. Semin Respir Infect 1999;14:151-62.
7. Raherison C, Peray P, Poirier R, Romand P, Grisnet J-P, Arsac P, et al. Management of lower respiratory tract infections by French general practitioners: the AIR II study. Eur Respir J 2002;19:314-9.
8. Holmes WF, Woodhead M. Providing better care for patients who may have pneumonia. Thorax 1999;54:925-8.
9. Macfarlane JT, Holmes WF, Macfarlane RM. Reducing reconsultations for acute lower respiratory tract illness with an information leaflet: a randomized controlled study of patients in primary care. Br J Gen Pract 1997;47:719-22.
10. Chandran R. Should we prescribe antibiotics for acute bronchitis? Am Fam Physician 2001;64:135-8.
11. Boldy DAR, Skidmore SJ, Ayres JG. Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine. Respir Med 1990;84:377-85.
12. Macfarlane J, Holmes W, Gard P, Thornhill D, Macfarlane R, Hubbard R. Reducing antibiotic use for acute bronchitis in primary care: blinded, randomized controlled trial of patient information leaflet. Br Med J 2002;12:91-4.
13. Becker L, Glazier R, McIsaac W, Smucny J. Antibiotics for acute bronchitis. In: The Cochrane library, Issue 3. Oxford: Update Software; 1999 [Cochrane review].
14. Smucny J, Fahey T, Becker L, Glazier R. Antibiotics for acute bronchitis. In: The Cochrane library, Issue 4. Chichester, UK: Wiley; 2003 [Cochrane review].
15. Arroll B, Kenealy T. Antibiotics for the common cold and acute purulent rhinitis. In: The Cochrane library, Issue 4. Chichester, UK: Wiley; 2003 [Cochrane review].
16. National Institutes of Health NHLBI. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. http://www.goldcopd.com/; 2003. Last accessed on 9 January 2004.
17. Feldman C. Acute exacerbations of chronic obstructive pulmonary disease. Guidelines for antibiotic management. SA Respir J 2003;9:44-51.
18. Stoller JK. Acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;236:988-94.
19. Hunter MH, King DE. COPD: management of acute exacerbations and chronic stable disease. Am Fam Physician 2001;64:603-12.
20. Adams SG, Melo J, Luther M, Anzueto A. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. Chest 2000;117:1345-52.
21. 1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:1090-5.
22. Stockley RA, O'Brien C, Pye A, Hill SL. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 2000;117:1638-45.
23. Gompertz S, O'Brien C, Bayley DL, Hill SL, Stockley RA. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J 2001;17:1112-9.
24. Heath JM, Mongia R. Chronic bronchitis: primary care management. Am Fam Physician 1998;57:2365-72, 2376-8.
25. 2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease. In.: The Cochrane library, Issue 4. Chichester, UK: Wiley; 2003 [Cochrane review].
26. Barr RG, Rowe BH, Camargo Jr CA. Methylxanthines for exacerbations of chronic obstructive pulmonary disease. In: The Cochrane library, Issue 2. Oxford: Update Software; 2002 [Cochrane review].
27. Wood-Baker R, Walters EH, Gibson P. Oral corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. In: The Cochrane library, Issue 2. Oxford: Update Software; 2002 [Cochrane review].
28. O'Donnell DE, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2003. Can Respir J 2003;10(Suppl A):11A-33A.
29. Kirchner JT. Do antibiotics reduce relapse of COPD exacerbations? Am Fam Physician 2000;62:2101.
30. Poole PJ, Black PN. Mucolytic agents for chronic bronchitis. In: The Cochrane library, Issue 2. Oxford: Update Software; 2002 [Cochrane review].
31. Tsirgiotis E, Ruffin R. Community-acquired pneumonia. A perspective for general practice. Aust Fam Physician 2000;29:639-45.
32. Finch R. Community acquired pneumonia. J R Coll Physicians 1998;32:328-32.
33. Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987;21:671-4.
34. Farr BM, Woodhead MA, Macfarlane JT, Bartlett CL, McCracken JS, Wadsworth J. Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community. Respir Med 2000;94:422-7.
35. File Jr TM. Community-acquired pneumonia. Lancet 2003;362:1991-2001.
36. Metlay JP, Fine MJ. Testing strategies in the initial management of patients with community-acquired pneumonia. Ann Intern Med 2003;138:109-18.
37. BTS guidelines for the management of community-acquired pneumonia in adults. Thorax 2001;56(Suppl IV):1-64.
38. Halm EA, Teirstein AS. Management of community-acquired pneumonia. N Engl J Med 2002;347:2039-45.
39. Woodhead M. Assessment of illness severity in community-acquired pneumonia: a useful new prediction tool? Thorax 2003;58:371-2.
40. Waterer GW, Somes GW, Wunderink RG. Monotherapy my be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 2001;161:1837-42.
41. Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999;159:2511-2.
42. Meehan TP, Fine MJ, Krumholz HM, Scinto JD, Galusha DH, Mockalis JT, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. J Am Med Assoc 1997;278:2080-4.